CSPIA
THTX

Cary Street Partners Investment Advisory’s Theratechnologies THTX Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio THTX Stock Details THTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-31
Closed -$67 – 1696
2023
Q3 		$67 Buy
+31
New +$66 ﹤0.01% 1855

Other funds holding THTX

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
CWP
Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Cary Street Partners Investment Advisory's THTX Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Theratechnologies (THTX) in Q4 2023, closing a stake of 31 shares — an estimated $67 sold.

Cary Street Partners Investment Advisory first reported a position in THTX in Q3 2023 and held it in 1 quarter. The position peaked at $67 in Q3 2023. 30 funds tracked by Wall St. Rank hold THTX as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Theratechnologies position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 31 Theratechnologies shares in Q4 2023, an estimated $67.
  • Cary Street Partners Investment Advisory first reported a position in Theratechnologies in Q3 2023 and held it in 1 quarter.
  • Cary Street Partners Investment Advisory's Theratechnologies position peaked at $67 in Q3 2023.
  • 30 funds tracked by Wall St. Rank held Theratechnologies as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.